Therefore, the reduction in ACE2 bioavailability after SARS-CoV-2 binding allows Ang II to be available to interact with AT1R, which mediates signals to activate NADPH oxidase and induce oxidative stress and inflammatory responses (Figure 1), which in turn contribute to the severity of COVID-19 [23,24]. The gene discussed is FMO5; the disease is COVID-19.